Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2617–2640 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Gastro-Intestinal Disorder
Interventions: Fecal microbiota transplant (FMT); Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 22 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Mild Cognitive Impairment, Dementia, Cognitive Impairment, Memory Loss
Interventions: Tele-Exergame Platform, No Tele-Exergame Platform; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 55 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Los Angeles, California • Houston, Texas

Conditions: Scapula Fracture, Glenoid; Fracture
Interventions: Scapular with glenoid neck fractures; Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 12
States / cities: Indianapolis, Indiana • Boston, Massachusetts • Ann Arbor, Michigan + 8 more

Conditions: Platelet Dysfunction Due to Aspirin
Interventions: aspirin; Drug
Lead sponsor: George Washington University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Atopic Dermatitis
Interventions: Nevisense electrical impedance spectroscopy; Device
Lead sponsor: Castle Biosciences Incorporated; Industry
Eligibility: 12 Years to 89 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 16
States / cities: Phoenix, Arizona • Los Angeles, California • Tampa, Florida + 13 more

Conditions: Metastatic Breast Cancer, Thyroid Dysfunction
Interventions: Triiodothyronine (T3); Drug
Lead sponsor: Aultman Health Foundation; Other
Eligibility: 18 Years to 105 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Canton, Ohio

Conditions: Dilated Cardiomyopathy (DCM), Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy, Heart Failure
Interventions: Allogeneic Cardiosphere-Derived Cells (CDCs); Biological
Lead sponsor: Capricor Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Myelodysplastic Syndrome, Effects of Chemotherapy, Mild Cognitive Impairment, Multiple Myeloma, Non-hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Acute Lymphoid Leukemia, Chronic Myeloid Leukemia, Acute Myeloid Leukemia
Interventions: Not listed
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Brain Diseases, Epilepsy, Memory Disorders, Traumatic Brain Injury, Cognitive Impairment, Post Traumatic Stress Disorder
Interventions: Intracranial Stimulation; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Skeletal Muscle Mitochondrial Dysfunction in the Elderly
Interventions: Elamipretide, Placebo; Drug
Lead sponsor: Stealth BioTherapeutics Inc.; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Functional Mitral Regurgitation
Interventions: Transmural Systems Transcatheter Mitral Cerclage Annuloplasty (TMCA); Device
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years to 99 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Atlanta, Georgia • Roanoke, Virginia

Conditions: Prostate Cancer, Sleep Disturbance, Fatigue, Cognitive Impairment
Interventions: teleCBT-I + SH/ReadiWatchTM, SH/ReadiWatchTM; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Overweight and Obesity, Endothelial Dysfunction, Cardiovascular Risk Factor
Interventions: Walnut Intake; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Davis, California

Conditions: Alzheimer's Disease
Interventions: MEM 1003, Placebo for MEM 1003; Drug
Lead sponsor: Memory Pharmaceuticals; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 57
States / cities: Northport, Alabama • Mesa, Arizona • Phoenix, Arizona + 51 more

Conditions: Mild Cognitive Impairment (MCI)
Interventions: Gamma- Glutamylcysteine, Gamma- Glutamylcusteine; Drug
Lead sponsor: Pravat Mandal; Other
Eligibility: 55 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pacemaker, Diastolic Dysfunction, Diastolic Heart Failure
Interventions: Adjustment of lower rate limit, Maintenance of lower rate limit; Device
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Tricuspid Valve Disease, Tricuspid Valve Insufficiency
Interventions: Tricuspid valve replacement with the Cor TRICUSPID ECM Valve; Device
Lead sponsor: Corvivo Cardiovascular, Inc.; Industry
Eligibility: Not listed
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Indianapolis, Indiana • New York, New York

Conditions: Head and Neck Cancer, Taste Dysfunction, Radiation Therapy
Interventions: Intraoral Device; Device
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Chronic Renal Insufficiency
Interventions: LHW090, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Orlando, Florida • Knoxville, Tennessee

Conditions: Endothelial Dysfunction, Hypertension
Interventions: Intralipid 20% @ 20cc/hour, Intralipid 20%@ 40cc/hour, Normal Saline, 32-gram oral fat load, 64-gram oral fat load; Drug · Dietary Supplement
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Renal Insufficiency
Interventions: fondaparinux sodium injection; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteopathic Medicine, Breast Feeding
Interventions: Sham, Osteopathic Manipulation, OMT; Other
Lead sponsor: Methodist Medical Center of Illinois; Other
Eligibility: 20 Hours to 2 Weeks
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Peoria, Illinois

Conditions: TBI (Traumatic Brain Injury), Brain Injuries, Stress, Attention Deficit, Executive Dysfunction
Interventions: State regulation skill training, Treatment-as-usual; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Postoperative Cognitive Dysfunction
Interventions: Midazolam (0.02mg/kg); Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 55 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).

Remote Game-based Exercise Program for Cognitive and Motor Function Improvement

Clinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous Injury

Genotypic and Phenotypic Correlates of Resistance to Aspirin

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma

Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

Amygdala Memory Enhancement

A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly

NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study

Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation Therapy

Influence of Walnut Intake on Vascular Function and Metabolism

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

Personalized Pacing: A New Paradigm for Patients With Diastolic Dysfunction or Heart Failure With Preserved Ejection Fraction

CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study

Intraoral Hypothermia Device for Preserving Taste During Radiation

An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

FFA-Induced Hypertension and Endothelial Dysfunction

"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"

Osteopathic Manipulation in Breastfed Newborns

Brain Markers of Improvements in Cognitive Functioning

Effect of Sedation on Cognitive Performance in the Elderly